Wolverine Stack

The Wolverine Stack offers a dual-peptide strategy — combining BPC-157 and TB-500 in a single, streamlined formulation — to support restoration, resilience, and recovery on multiple fronts. Designed for those seeking enhanced structural repair, connective tissue integrity, and overall regenerative capacity, this stack brings together two of the most studied peptides in the recovery and performance space.

BPC-157 (Body Protection Compound): Known for promoting angiogenesis — the formation of new blood vessels — which helps deliver oxygen and nutrients into tissues undergoing repair. It also supports cellular migration and has been researched in contexts of gut health and gastrointestinal repair.

TB-500: A synthetic fragment of thymosin beta-4, this peptide supports regulation of actin (a key structural protein within cells) and promotes actin remodelling — the reorganization of cellular scaffolding that helps cells move and rebuild tissue — assisting in tissue flexibility, mobility, and repair.

By combining these two carefully selected peptides, the Wolverine Stack supports the body's ability to repair and renew deep structural systems — from muscle and tendon to ligament and connective tissue — promoting resilience and recovery at a foundational level.

While many clinics charge premium per-session pricing for combination peptide therapies, WYN offers the complete Wolverine Stack for $259 per month with a two-month commitment, or $279 for a single-month supply.

Each batch is compounded in an FDA-registered, USP <797> cleanroom, ensuring potency and purity. Our direct partnership with the compounding facility allows us to bypass retail markups and deliver superior medical-grade quality at a fraction of typical med-spa prices, bringing powerful recovery within reach.

The Wolverine Stack works by reinforcing the body's own regenerative frameworks. While BPC-157 and TB-500 have been extensively studied individually, their combination allows for complementary support across multiple repair pathways — including vascular growth, cellular migration, connective tissue remodeling, and inflammation modulation.

Animal and early human data on BPC-157 show strong support for angiogenic activity and tissue repair. Meanwhile, TB-500 has been the subject of research into cellular migration and structural repair in soft tissue models.

By leveraging both peptides in a single stack, the goal is to support synergistic repair — enabling the body not only to heal, but to strengthen underlying architecture and promote optimal functional outcomes.

• Noticeable reduction in connective-tissue discomfort or stiffness
• Feeling of improved recovery after exertion or strain
• Enhanced mobility and flexibility in previously tight or overused areas
• Perceived increase in structural stability around joints, tendons, or ligaments
• Gradual progression toward more resilient, less aggravated tissue (less soreness, faster bounce-back)
• Overall increased sense of foundational repair and readiness for physical activity

• Concentration: 3 mg BPC-157 + 3 mg TB-500 per 1 mL
• Vial Size: 5 mL
• Formulation: Injectable, ready-to-use
• Facility: Compounded in FDA-registered, USP-compliant pharmacy
• Storage: Refrigerate between 36–46°F (2–8°C)
• Pricing: Transparent and consistent — includes shipping, syringes, and alcohol swabs; no hidden fees or subscriptions